Sheri Trutwin

Sheri Trutwin is an experienced professional in the pharmaceutical industry, currently serving as the Head of Strategic Accounts & IDN Program at Alnylam Pharmaceuticals. Previously, Sheri held multiple leadership positions at Acadia Pharmaceuticals Inc., including Senior National Director Health Systems and Key Accounts, National Director and Head of Market Development and Key Accounts, and Senior Regional Manager. Earlier experience includes the role of Director of Business Operations and Sales at Osiris Therapeutics, Senior Business Director - Regenerative Medicine at Shire, and Senior Area Sales Director for MS Neurology & Nephrology at Questcor Pharmaceuticals, Inc. Sheri demonstrates a strong background in strategic account management and business operations within health systems.